View in EDS HTML Full Text PDF Full Text

Open-label phase II clinical trial of orteronel (TAK-700) in metastatic or advanced non-resectable granulosa cell ovarian tumors: the Greko II study (GETHI2013-01).

Saved in:
Bibliographic Details
Title: Open-label phase II clinical trial of orteronel (TAK-700) in metastatic or advanced non-resectable granulosa cell ovarian tumors: the Greko II study (GETHI2013-01).
Authors: Garcia-Donas J; HM CIOCC MADRID (Centro Integral Oncológico Clara Campal), Laboratorio de Innovación en Oncología, Instituto de Investigación Sanitaria HM Hospitales, Oña Street 10, 28050, Madrid, Spain. jgarciadonas@gmail.com., Garrigos L; Hospital del Mar, Barcelona, Spain., Lainez N; Complejo Hospitalario de Navarra, Pamplona, Navarra, Spain., Santaballa A; Hospital Universitari i Politècnic La Fe, Valencia, Spain., Redondo A; Hospital Universitario La Paz, Madrid, Spain., Cueva JF; Complejo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Galicia, Spain., Rubio MJ; Hospital Reina Sofia, Córdoba, Andalucia, Spain., Prieto M; Laboratorio de Dianas Terapeuticas (CIOCC), Hospital HM Sanchinarro, Madrid, Spain., Lopez-Guerrero JA; Laboratory of Molecular Biology, Fundacion Instituto Valenciano de Oncología (FIVO), Valencia, Spain., Garcia-Casado Z; Laboratory of Molecular Biology, Fundacion Instituto Valenciano de Oncología (FIVO), Valencia, Spain., Barquin A; HM CIOCC MADRID (Centro Integral Oncológico Clara Campal), Laboratorio de Innovación en Oncología, Instituto de Investigación Sanitaria HM Hospitales, Oña Street 10, 28050, Madrid, Spain., Grande E; MD Anderson Cancer Center Madrid, Madrid, Spain., Alia EG; Hospital Universitario Ramón y Cajal, Madrid, Spain., Sevillano E; HM CIOCC MADRID (Centro Integral Oncológico Clara Campal), Laboratorio de Innovación en Oncología, Instituto de Investigación Sanitaria HM Hospitales, Oña Street 10, 28050, Madrid, Spain., Bover I; Hospital Son Llàtzer, Palma, Islas Baleares, Spain., Grazioso TP; HM CIOCC MADRID (Centro Integral Oncológico Clara Campal), Laboratorio de Innovación en Oncología, Instituto de Investigación Sanitaria HM Hospitales, Oña Street 10, 28050, Madrid, Spain., Sanchez-Escribano R; Hospital Universitario de Burgos, Burgos, Spain., Hurtado A; Hospital Universitario Fundación de Alcorcón, Alcorcón, Spain., Navarro P; HM CIOCC MADRID (Centro Integral Oncológico Clara Campal), Laboratorio de Innovación en Oncología, Instituto de Investigación Sanitaria HM Hospitales, Oña Street 10, 28050, Madrid, Spain., Rodriguez-Moreno JF; HM CIOCC MADRID (Centro Integral Oncológico Clara Campal), Laboratorio de Innovación en Oncología, Instituto de Investigación Sanitaria HM Hospitales, Oña Street 10, 28050, Madrid, Spain.
Source: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2025 Jul; Vol. 27 (7), pp. 3223-3231. Date of Electronic Publication: 2024 Dec 30.
Publication Type: Journal Article; Clinical Trial, Phase II; Multicenter Study
Journal Info: Publisher: Springer Italia Country of Publication: Italy NLM ID: 101247119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39738931
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Open-label phase II clinical trial of orteronel (TAK-700) in metastatic or advanced non-resectable granulosa cell ovarian tumors: the Greko II study (GETHI2013-01).
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Garcia-Donas+J%22">Garcia-Donas J</searchLink>; HM CIOCC MADRID (Centro Integral Oncológico Clara Campal), Laboratorio de Innovación en Oncología, Instituto de Investigación Sanitaria HM Hospitales, Oña Street 10, 28050, Madrid, Spain. jgarciadonas@gmail.com.<br /><searchLink fieldCode="AU" term="%22Garrigos+L%22">Garrigos L</searchLink>; Hospital del Mar, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Lainez+N%22">Lainez N</searchLink>; Complejo Hospitalario de Navarra, Pamplona, Navarra, Spain.<br /><searchLink fieldCode="AU" term="%22Santaballa+A%22">Santaballa A</searchLink>; Hospital Universitari i Politècnic La Fe, Valencia, Spain.<br /><searchLink fieldCode="AU" term="%22Redondo+A%22">Redondo A</searchLink>; Hospital Universitario La Paz, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Cueva+JF%22">Cueva JF</searchLink>; Complejo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Galicia, Spain.<br /><searchLink fieldCode="AU" term="%22Rubio+MJ%22">Rubio MJ</searchLink>; Hospital Reina Sofia, Córdoba, Andalucia, Spain.<br /><searchLink fieldCode="AU" term="%22Prieto+M%22">Prieto M</searchLink>; Laboratorio de Dianas Terapeuticas (CIOCC), Hospital HM Sanchinarro, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Lopez-Guerrero+JA%22">Lopez-Guerrero JA</searchLink>; Laboratory of Molecular Biology, Fundacion Instituto Valenciano de Oncología (FIVO), Valencia, Spain.<br /><searchLink fieldCode="AU" term="%22Garcia-Casado+Z%22">Garcia-Casado Z</searchLink>; Laboratory of Molecular Biology, Fundacion Instituto Valenciano de Oncología (FIVO), Valencia, Spain.<br /><searchLink fieldCode="AU" term="%22Barquin+A%22">Barquin A</searchLink>; HM CIOCC MADRID (Centro Integral Oncológico Clara Campal), Laboratorio de Innovación en Oncología, Instituto de Investigación Sanitaria HM Hospitales, Oña Street 10, 28050, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Grande+E%22">Grande E</searchLink>; MD Anderson Cancer Center Madrid, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Alia+EG%22">Alia EG</searchLink>; Hospital Universitario Ramón y Cajal, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Sevillano+E%22">Sevillano E</searchLink>; HM CIOCC MADRID (Centro Integral Oncológico Clara Campal), Laboratorio de Innovación en Oncología, Instituto de Investigación Sanitaria HM Hospitales, Oña Street 10, 28050, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Bover+I%22">Bover I</searchLink>; Hospital Son Llàtzer, Palma, Islas Baleares, Spain.<br /><searchLink fieldCode="AU" term="%22Grazioso+TP%22">Grazioso TP</searchLink>; HM CIOCC MADRID (Centro Integral Oncológico Clara Campal), Laboratorio de Innovación en Oncología, Instituto de Investigación Sanitaria HM Hospitales, Oña Street 10, 28050, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Sanchez-Escribano+R%22">Sanchez-Escribano R</searchLink>; Hospital Universitario de Burgos, Burgos, Spain.<br /><searchLink fieldCode="AU" term="%22Hurtado+A%22">Hurtado A</searchLink>; Hospital Universitario Fundación de Alcorcón, Alcorcón, Spain.<br /><searchLink fieldCode="AU" term="%22Navarro+P%22">Navarro P</searchLink>; HM CIOCC MADRID (Centro Integral Oncológico Clara Campal), Laboratorio de Innovación en Oncología, Instituto de Investigación Sanitaria HM Hospitales, Oña Street 10, 28050, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Rodriguez-Moreno+JF%22">Rodriguez-Moreno JF</searchLink>; HM CIOCC MADRID (Centro Integral Oncológico Clara Campal), Laboratorio de Innovación en Oncología, Instituto de Investigación Sanitaria HM Hospitales, Oña Street 10, 28050, Madrid, Spain.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101247119%22">Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico</searchLink> [Clin Transl Oncol] 2025 Jul; Vol. 27 (7), pp. 3223-3231. <i>Date of Electronic Publication: </i>2024 Dec 30.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase II; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Italia%22">Springer Italia </searchLink><i>Country of Publication: </i>Italy <i>NLM ID: </i>101247119 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1699-3055 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221699048X%22">1699048X </searchLink><i>NLM ISO Abbreviation: </i>Clin Transl Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39738931
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s12094-024-03827-4
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 3223
    Titles:
      – TitleFull: Open-label phase II clinical trial of orteronel (TAK-700) in metastatic or advanced non-resectable granulosa cell ovarian tumors: the Greko II study (GETHI2013-01).
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Garcia-Donas J
      – PersonEntity:
          Name:
            NameFull: Garrigos L
      – PersonEntity:
          Name:
            NameFull: Lainez N
      – PersonEntity:
          Name:
            NameFull: Santaballa A
      – PersonEntity:
          Name:
            NameFull: Redondo A
      – PersonEntity:
          Name:
            NameFull: Cueva JF
      – PersonEntity:
          Name:
            NameFull: Rubio MJ
      – PersonEntity:
          Name:
            NameFull: Prieto M
      – PersonEntity:
          Name:
            NameFull: Lopez-Guerrero JA
      – PersonEntity:
          Name:
            NameFull: Garcia-Casado Z
      – PersonEntity:
          Name:
            NameFull: Barquin A
      – PersonEntity:
          Name:
            NameFull: Grande E
      – PersonEntity:
          Name:
            NameFull: Alia EG
      – PersonEntity:
          Name:
            NameFull: Sevillano E
      – PersonEntity:
          Name:
            NameFull: Bover I
      – PersonEntity:
          Name:
            NameFull: Grazioso TP
      – PersonEntity:
          Name:
            NameFull: Sanchez-Escribano R
      – PersonEntity:
          Name:
            NameFull: Hurtado A
      – PersonEntity:
          Name:
            NameFull: Navarro P
      – PersonEntity:
          Name:
            NameFull: Rodriguez-Moreno JF
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2025 Jul
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1699-3055
          Numbering:
            – Type: volume
              Value: 27
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
              Type: main
ResultId 1